Skip to main navigation Skip to search Skip to main content

Acrosoxacin in the treatment of uncomplicated gonorrhoea

  • R. J. Walsh
  • , R. Scott
  • , J. B. Bittiner
  • , M. Shahidullah
  • , R. C.B. Slack*
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    5 Citations (Scopus)

    Abstract

    Acrosoxacin was given as a single 300 mg oral dose to 105 patients with acute gonorrhoea. Of the 100 patients followed completely there was a 93% cure rate and 33% of men developed postgonococcal urethritis (PGU). This compared with a 97% cure and 30% PGU with 2 megaunits penicillin. The in vitro activity of acrosoxacin in Nottingham against strains of Neisseria gonorrhoeae showed that it was a highly active agent with 90070 of strains inhibited by a concentration of 0-03 mg/l.

    Original languageEnglish
    Pages (from-to)242-244
    Number of pages3
    JournalSexually Transmitted Infections
    Volume59
    Issue number4
    DOIs
    Publication statusPublished - 1983

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Acrosoxacin in the treatment of uncomplicated gonorrhoea'. Together they form a unique fingerprint.

    Cite this